1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Mitral Valve Annuloplasty Devices Overview
3 Products under Development
3.1 Mitral Valve Annuloplasty Devices - Pipeline Products by Stage of Development
3.2 Mitral Valve Annuloplasty Devices - Pipeline Products by Territory
3.3 Mitral Valve Annuloplasty Devices - Pipeline Products by Regulatory Path
3.4 Mitral Valve Annuloplasty Devices - Pipeline Products by Estimated Approval Date
3.5 Mitral Valve Annuloplasty Devices - Ongoing Clinical Trials
4 Mitral Valve Annuloplasty Devices - Pipeline Products under Development by Companies
4.1 Mitral Valve Annuloplasty Devices Companies - Pipeline Products by Stage of Development
4.2 Mitral Valve Annuloplasty Devices - Pipeline Products by Stage of Development
5 Mitral Valve Annuloplasty Devices Companies and Product Overview
5.1 Affluent Medical SASU Company Overview
5.1.1 Affluent Medical SASU Pipeline Products & Ongoing Clinical Trials Overview
5.2 Anchorvalve Company Overview
5.2.1 Anchorvalve Pipeline Products & Ongoing Clinical Trials Overview
5.3 Boston Scientific Corp Company Overview
5.3.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.4 CUBE SRL Company Overview
5.4.1 CUBE SRL Pipeline Products & Ongoing Clinical Trials Overview
5.5 HVR Cardio Oy Company Overview
5.5.1 HVR Cardio Oy Pipeline Products & Ongoing Clinical Trials Overview
5.6 MiCardia Corp Company Overview
5.6.1 MiCardia Corp Pipeline Products & Ongoing Clinical Trials Overview
5.7 Michigan Critical Care Consultants Inc Company Overview
5.7.1 Michigan Critical Care Consultants Inc Pipeline Products & Ongoing Clinical Trials Overview
5.8 Millipede LLC Company Overview
5.8.1 Millipede LLC Pipeline Products & Ongoing Clinical Trials Overview
5.9 Mitre Medical Corp Company Overview
5.9.1 Mitre Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
5.10 Rambam Health Care Campus Company Overview
5.10.1 Rambam Health Care Campus Pipeline Products & Ongoing Clinical Trials Overview
5.11 Syntach AB Company Overview
5.11.1 Syntach AB Pipeline Products & Ongoing Clinical Trials Overview
5.12 Tau Pnu Medical Co., Ltd. Company Overview
5.12.1 Tau Pnu Medical Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.13 TransCardiac Therapeutics, LLC (Inactive) Company Overview
5.13.1 TransCardiac Therapeutics, LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.14 Transmural systems LLC Company Overview
5.14.1 Transmural systems LLC Pipeline Products & Ongoing Clinical Trials Overview
5.15 TTK Healthcare Ltd Company Overview
5.15.1 TTK Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.16 Valcare Medical Company Overview
5.16.1 Valcare Medical Pipeline Products & Ongoing Clinical Trials Overview
5.17 Valtech Cardio Ltd Company Overview
5.17.1 Valtech Cardio Ltd Pipeline Products & Ongoing Clinical Trials Overview
6 Mitral Valve Annuloplasty Devices- Recent Developments
6.1 Jun 04, 2024: Medtronic Announces Dr. Goran Petrovski to Join Diabetes Medical Affairs Team
6.2 Jun 04, 2024: Medtronic Announces Retirement of Rob Ten Hoedt as Executive Vice President and President, Global Regions, Effective as of June 28, 2024
6.3 May 14, 2024: Valcare Medical Announces Enrollment of First Two Patients in AMEND TS EU Pilot Study
6.4 Apr 25, 2024: Edwards Lifesciences Reports First Quarter Results
6.5 Apr 24, 2024: Medtronic Names Yarmela Pavlovic as Chief Regulatory Officer
6.6 Apr 22, 2024: Genesee BioMedical Receives FDA 510(k) Clearance for TransForm McCarthy Mitral Annuloplasty Ring (TF)
6.7 Apr 15, 2024: Edwards Lifesciences Appoints New China Head
6.8 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference
6.9 Feb 23, 2024: Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
6.10 Jan 15, 2024: Affluent Medical : Pre-submission Dossier for the 510(K) of Medical Device Kaliostm Filed With FDA for Review
6.11 Oct 18, 2023: Edwards Lifesciences to Host Earnings Conference Call on October 25, 2023
6.12 Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business
6.13 Sep 13, 2023: Affluent Medical announces positive clinical results and further insights to enhance its strategy on Structural Heart activities
6.14 Aug 28, 2023: Edwards Lifesciences to Present at the 2023 Wells Fargo Healthcare Conference
6.15 Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair
6.16 Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024
7 Appendix
7.1 Methodology
7.2 About the Analyst
7.3 Contact the Publisher
7.4 Disclaimer